Gateway Pharmacy and Sarhaddi Pharmaceutical Inc. are aware of fraudulent emails and websites falsely offering employment opportunities in our name.
We never request payment from applicants. If you receive suspicious communications claiming to represent our company, please contact us directly to verify authenticity.
A new national study finds GLP-1 weight-loss medications are becoming the dominant treatment for obesity in teens and young adults, while researchers say guidance on how to use these therapies is still evolving.
Health News is provided as a service to Gateway Pharmacy site users by HealthDay. Gateway Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.